Blueshift Asset Management, LLC Exact Sciences Corp Transaction History

Blueshift Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$65.94 - $99.04 $388,188 - $583,048	5,887 New	5,887 $401,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $87,182 - $134,631	2,727 Added 14.46%	21,586 $701,000
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $858,022 - $1.84 Million	-24,095 Reduced 56.09%	18,859 $743,000
Q1 2022 May 12, 2022	BUY	$57.56 - $82.54 $2.47 Million - $3.55 Million	42,954 New	42,954 $3 Million
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $1.01 Million - $1.4 Million	-13,873 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $1.25 Million - $1.72 Million	13,873 New	13,873 $1.32 Million
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $305,170 - $840,950	-8,052 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $103,132 - $132,454	1,328 Added 19.75%	8,052 $745,000
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $607,647 - $823,622	6,724 New	6,724 $608,000

666

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.81B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.